BACKGROUND: Chagas disease is caused by the parasite Trypanosoma cruzi and is endemic in much of Latin America. With increased globalisation and immigration, it is a risk in any country, partly through congenital transmission. The frequency of congenital transmission is unclear. OBJECTIVE: To assess the frequency of congenital transmission of T. cruzi. SEARCH STRATEGY: PubMed, Journals@Ovid Full Text, EMBASE, CINAHL, Fuente Academica and BIREME databases were searched using seven search terms related to Chagas disease or T. cruzi and congenital transmission. SELECTION CRITERIA: The inclusion criteria were the following: Dutch, English, French, Portuguese or Spanish language; case report, case series or observational study; original data on congenital T. cruzi infection in humans; congenital infection rate reported or it could be derived. This systematic review included 13 case reports/series and 51 observational studies. DATA COLLECTION AND ANALYSIS: Two investigators independently collected data on study characteristics, diagnosis and congenital infection rate. The principal summary measure--the congenital transmission rate--is defined as the number of congenitally infected infants divided by the number of infants born to infected mothers. A random effects model was used. MAIN RESULTS: The pooled congenital transmission rate was 4.7% (95% confidence interval: 3.9-5.6%). Countries where T. cruzi is endemic had a higher rate of congenital transmission compared with countries where it is not endemic (5.0% versus 2.7%). CONCLUSIONS: Congenital transmission of Chagas disease is a global problem. Overall risk of congenital infection in infants born to infected mothers is about 5%. The congenital mode of transmission requires targeted screening to prevent future cases of Chagas disease.
BACKGROUND:Chagas disease is caused by the parasite Trypanosoma cruzi and is endemic in much of Latin America. With increased globalisation and immigration, it is a risk in any country, partly through congenital transmission. The frequency of congenital transmission is unclear. OBJECTIVE: To assess the frequency of congenital transmission of T. cruzi. SEARCH STRATEGY: PubMed, Journals@Ovid Full Text, EMBASE, CINAHL, Fuente Academica and BIREME databases were searched using seven search terms related to Chagas disease or T. cruzi and congenital transmission. SELECTION CRITERIA: The inclusion criteria were the following: Dutch, English, French, Portuguese or Spanish language; case report, case series or observational study; original data on congenital T. cruzi infection in humans; congenital infection rate reported or it could be derived. This systematic review included 13 case reports/series and 51 observational studies. DATA COLLECTION AND ANALYSIS: Two investigators independently collected data on study characteristics, diagnosis and congenital infection rate. The principal summary measure--the congenital transmission rate--is defined as the number of congenitally infectedinfants divided by the number of infants born to infected mothers. A random effects model was used. MAIN RESULTS: The pooled congenital transmission rate was 4.7% (95% confidence interval: 3.9-5.6%). Countries where T. cruzi is endemic had a higher rate of congenital transmission compared with countries where it is not endemic (5.0% versus 2.7%). CONCLUSIONS: Congenital transmission of Chagas disease is a global problem. Overall risk of congenital infection in infants born to infected mothers is about 5%. The congenital mode of transmission requires targeted screening to prevent future cases of Chagas disease.
Authors: A Angheben; M Anselmi; F Gobbi; S Marocco; G Monteiro; D Buonfrate; S Tais; M Talamo; G Zavarise; M Strohmeyer; F Bartalesi; A Mantella; M Di Tommaso; Kh Aiello; G Veneruso; G Graziani; Mm Ferrari; I Spreafico; E Bonifacio; G Gaiera; M Lanzafame; M Mascarello; G Cancrini; P Albajar-Vinas; Z Bisoffi; A Bartoloni Journal: Euro Surveill Date: 2011-09-15
Authors: Maria Okumura; Vera Aparecida dos Santos; Mário E Camargo; Regina Schultz; Marcelo Zugaib Journal: Prenat Diagn Date: 2004-03 Impact factor: 3.050
Authors: Jaime A Costales; Amaya Sánchez-Gómez; Luis C Silva-Aycaguer; William Cevallos; Susana Tamayo; César A Yumiseva; Jerry O Jacobson; Luiggi Martini; Caty A Carrera; Mario J Grijalva Journal: Am J Trop Med Hyg Date: 2015-02-09 Impact factor: 2.345
Authors: Léa Campos de Oliveira; Natalia Bueno Pereira; Carlos Henrique Valente Moreira; Ana Luiza Bierrenbach; Flavia Cristina Salles; Marcela de Souza-Basqueira; Erika Regina Manuli; Ariela Mota Ferreira; Cláudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino Journal: Am J Trop Med Hyg Date: 2020-04 Impact factor: 2.345
Authors: Ana Beatriz Bortolozo de Oliveira; Kaio Cesar Chaboli Alevi; Carlos Henrique Lima Imperador; Fernanda Fernandez Madeira; Maria Tercília Vilela de Azeredo-Oliveira Journal: Am J Trop Med Hyg Date: 2018-03 Impact factor: 2.345
Authors: Ana Beatriz Bortolozo de Oliveira; Aline Rimoldi Ribeiro; Fernanda Fernandez Madeira; Natália Regina Cesaretto; João Aristeu da Rosa; Maria Tercília Vilela de Azeredo-Oliveira; Kaio Cesar Chaboli Alevi Journal: Am J Trop Med Hyg Date: 2019-09 Impact factor: 2.345
Authors: Pierre Buekens; María Luisa Cafferata; Jackeline Alger; Fernando Althabe; José M Belizán; Norma Bustamante; Yves Carlier; Alvaro Ciganda; Jaime H Del Cid; Eric Dumonteil; Rubí Gamboa-León; Jorge A García; Luz Gibbons; Olga Graiff; Jesús Gurubel Maldonado; Claudia Herrera; Elizabeth Howard; Laura Susana Lara; Benjamín López; María Luisa Matute; María Jesús Ramírez-Sierra; María Cecilia Robles; Sergio Sosa-Estani; Carine Truyens; Christian Valladares; Dawn M Wesson; Concepción Zúniga Journal: Am J Trop Med Hyg Date: 2017-11-30 Impact factor: 2.345
Authors: April L Kendricks; Stanton B Gray; Gregory K Wilkerson; Courtney M Sands; Christian R Abee; Bruce J Bernacky; Peter J Hotez; Maria Elena Bottazzi; Suzanne L Craig; Kathryn M Jones Journal: Comp Med Date: 2020-03-17 Impact factor: 0.982